The Antitumor Constituents from Hedyotis Diffusa Willd
AbstractAs a TCM, Hedyotis diffusa Willd. has been using to treat malignant tumors, and many studies also showed that the extracts from Hedyotis diffusa Willd. possessed evident antitumor activities. Therefore, we carried out chemical study on Hedyotis diffusa Willd. and investigated the cytotoxicity of the obtained compounds on a panel of eight tumor cell lines. As a result, four new compounds were isolated from Hedyotis diffusa Willd., including three iridoid glycosides of Shecaoiridoidside A–C (1–3) and a cerebroside of shecaocerenoside A (4). Also, six known iridoid compounds (5–10) were also obtained. The cytotoxicity of all compounds against human tumor cell lines of HL-60, HeLa, HCT15, A459, HepG2, PC-3, CNE-2, and BCG-823 were also evaluated in vitro. New compound 3 exhibited evident cytotoxicity to all tumor cell lines except the Hela, and the IC50 values are from 9.6 µM to 62.2 µM, while new compound 4 showed moderate cytotoxicity to all the cell lines, and the IC50 values are from 33.6 µM to 89.3 µM. By contrast, new compound 1 and known compound 9 showed moderate cytotoxicity to HCT15, A459, and HepG2 selectively. Known compound 7 also exhibited moderate cytotoxicity to HCT15 and A459 selectively. View Full-Text
Share & Cite This Article
Wang, C.; Zhou, X.; Wang, Y.; Wei, D.; Deng, C.; Xu, X.; Xin, P.; Sun, S. The Antitumor Constituents from Hedyotis Diffusa Willd. Molecules 2017, 22, 2101.
Wang C, Zhou X, Wang Y, Wei D, Deng C, Xu X, Xin P, Sun S. The Antitumor Constituents from Hedyotis Diffusa Willd. Molecules. 2017; 22(12):2101.Chicago/Turabian Style
Wang, Changfu; Zhou, Xuegang; Wang, Youzhi; Wei, Donghua; Deng, Chengjie; Xu, Xiaoyun; Xin, Ping; Sun, Shiqin. 2017. "The Antitumor Constituents from Hedyotis Diffusa Willd." Molecules 22, no. 12: 2101.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.